Showing 41 to 60 of 1,717 approvalsPage 3 of 86

Yuvanci

Authorisation: Sep 27, 2024

Janssen-Cilag International NV

Fymskina

Authorisation: Sep 25, 2024

Formycon AG

Fymskina

Authorisation: Sep 25, 2024

Formycon AG

Otulfi

Authorisation: Sep 25, 2024

Fresenius Kabi Deutschland Gmbh

Ituxredi

Authorisation: Sep 19, 2024

Reddy Holding GmbH

Ituxredi

Authorisation: Sep 19, 2024

Reddy Holding GmbH

Epruvy (previously Ranibizumab Midas)

Authorisation: Sep 19, 2024

Midas Pharma Gmbh

Vevizye

Authorisation: Sep 19, 2024

Laboratoires Théa SAS

Iqirvo

Authorisation: Sep 19, 2024

IPSEN PHARMA

Iqirvo

Authorisation: Sep 19, 2024

IPSEN PHARMA

Anzupgo

Authorisation: Sep 19, 2024

LEO Pharma A/S

Loqtorzi

Authorisation: Sep 19, 2024

TOPALLIANCE BIOSCIENCES EUROPE LIMITED

Axitinib Accord

Authorisation: Sep 19, 2024

ACCORD HEALTHCARE SL

Axitinib Accord

Authorisation: Sep 19, 2024

ACCORD HEALTHCARE SL

Tuznue

Authorisation: Sep 19, 2024

Prestige Biopharma Belgium

Kayfanda

Authorisation: Sep 19, 2024

IPSEN PHARMA

Vyloy

Authorisation: Sep 19, 2024

ASTELLAS PHARMA EUROPE B.V.

Eksunbi

Authorisation: Sep 12, 2024

Samsung Bioepis NL B.V.

Akantior

Authorisation: Aug 22, 2024

SIFI SPA

Winrevair

Authorisation: Aug 22, 2024

Merck Sharp & Dohme BV

• Prev
• 1
• 2
• 3
• 4
• 5
• 86
• Next